Epigenetics and Epigenomics of Diabetes

Track 09: Epigenetics and Epigenomics of Diabetes

Epigenetics investigates cellular influence on gene activity without DNA sequence changes, while epigenomics explores broader alterations in gene control. These changes are linked to conditions like prediabetes, obesity, and insulin resistance.

Diabetes, a metabolic disorder, results from genetic and environmental factors. Its global prevalence raises treatment costs and complications. The disease is attributed to genetic predisposition and significant gene alterations.

  • Epigenetic Reprogramming
  • Epigenetic Variation
  • Epigenetic Signals

 

    Related Conference of Epigenetics and Epigenomics of Diabetes

    July 23-24, 2026

    37th European Heart and Heart Failure Congress

    Paris, France
    August 27-28, 2026

    22nd Global Biomarkers and Clinical Research Summit

    Paris, France
    September 14-15, 2026

    7th Global Summit on Digital Therapeutics

    Barcelona, Spain
    September 28-29, 2026

    13th International Conference on Stroke and Neurological Disorders

    Amsterdam, Netherlands
    October 19-20, 2026

    6th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    November 16-17, 2026

    11th Global Summit on Midwifery and Womens Health

    Tokyo, Japan
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands
    January 18-19, 2027

    10th World Congress on PCOS and Reproductive Healthcare

    Bangkok, Thailand
    January 18-19, 2027

    44th International Conference on Women's Health

    Bangkok, Thailand
    February 01-02, 2027

    9th International Conference on Digital Health

    London, UK

    Epigenetics and Epigenomics of Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in